Memo Updates from McLendon Clinical Lab

Please read the following memos: CMS-mandated changes in HIV antibody test orders, New Test: CYP2C19 genotyping to detect resistance to clopidogrel, and New Interpretive Comments Associated with the TDx FLM Assay.

CMS-mandated changes in HIV antibody test orders
Please review this memo discussing CMS-mandated changes in HIV antibody test orders.


New Test: CYP2C19 genotyping to detect resistance to clopidogrel
Please review this memo discussing a new test to detect cytochrome P450 2C19 (CYP2C19) sequence variants associated with resistance to clopidogrel.


New Interpretive Comments Associated with the TDx FLM Assay
Please review this memo discussing new interpretive comments associated with the TDx FLM Assay.
 



Filed under: